RU

Russia

6906 clinical trials

Find Trials

Clinical Trials (6906)

Showing 20 of 6,906 trialsScroll for more
NCT0593912819 sites

A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA

Active Not Recruiting
NCT07854704Not Applicable1 site

Goal-Directed Temperature Management During Prolonged Abdominal Surgery

Recruiting
NCT05862285Phase 33 sites

A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study

Recruiting
NCT03486873Phase 337 sites

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting
NCT03460977Phase 19 sites

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Recruiting
NCT04736706Phase 39 sites

A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

Active Not Recruiting
NCT05203172Phase 43 sites

The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

Recruiting

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Recruiting
NCT06534892Phase 39 sites

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Active Not Recruiting
NCT04629248Phase 33 sites

A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

Active Not Recruiting
NCT07324837Phase 317 sites

Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset

Recruiting
NCT07853482Not Applicable1 site

TAP vs. ESP Blocks for Post-Cesarean Analgesia: A Randomized Controlled Trial

Not Yet Recruiting
NCT05134441Phase 312 sites

Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

Active Not Recruiting
NCT04729621Phase 38 sites

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

Completed
NCT07850960Phase 41 site

Effect of Omeprazole on Gut Microbiota in Adults With Obesity and GERD

Not Yet Recruiting
NCT05201638Phase 325 sites

Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

Active Not Recruiting
NCT01804686Phase 318 sites

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Active Not Recruiting
NCT01983241Phase 33 sites

Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)

Completed
NCT01168791Phase 34 sites

Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma

Terminated
NCT01555710Phase 311 sites

Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)

Terminated